Colon Cancer Liver Metastasis Clinical Trial
Official title:
A Randomized Controlled Trial of TACE Hepatic Artery Infusion of Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
The purpose of this study was a randomized controlled trial to compare the effect of oxaliplatin and raltitrexed treatment of colorectal cancer with liver metastases by TACE hepatic artery infusion
Colorectal cancer is one of the most common malignancies, with 1 million new cases and half a million deaths each year worldwide. The development of metastases is the main cause of death. Liver metastases are diagnosed in 10-25% of patients at the time of resection of their primary colorectal tumor and, eventually, up to 70% of patients with colorectal cancer develop liver metastases.Oxaliplatin and raltitrexed were used for the treatment of colorectal cancer with liver metastases. We aimed to perform a randomized controlled trial to compare the effect of oxaliplatin and raltitrexed treatment of colorectal cancer with liver metastases by TACE hepatic artery infusion. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01540435 -
Perioperative Treatment of Resectable Liver Metastases
|
Phase 2 | |
| Terminated |
NCT01464593 -
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
|
Phase 2 | |
| Completed |
NCT02090816 -
Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy
|
N/A | |
| Recruiting |
NCT04682665 -
Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
|
||
| Completed |
NCT01730365 -
Optical Detection of Malignancy During Percutaneous Interventions
|
N/A | |
| Completed |
NCT01526200 -
Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
|
N/A | |
| Terminated |
NCT03370198 -
Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02781935 -
Diffusion-Weighted MRI for Liver Metastasis
|
||
| Completed |
NCT01891552 -
Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
|
N/A | |
| Recruiting |
NCT05293041 -
Argipressin's Influence on Blood Loss During Hepatic Resection
|
Phase 4 | |
| Recruiting |
NCT02631564 -
Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis
|
N/A | |
| Recruiting |
NCT03175016 -
Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02363049 -
Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
|
Phase 3 | |
| Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04668872 -
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
|
||
| Completed |
NCT01522209 -
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
|
N/A | |
| Active, not recruiting |
NCT03310008 -
Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
|
Phase 1 |